animal-type melanoma cellular blue nevus epithelioid blue nevus malignant melanoma pigmented epithelioid melanocytoma a b s t r a c t Pigmented epithelioid melanocytoma (PEM), or animal-type melanoma, is an unusual variant of melanoma which has been reported to have indolent behavior and a relatively good prognosis. We report a 12-year-old girl with PEM on the third finger web of her right hand. Histopathologically, it was composed of heavily pigmented dermal epithelioid and spindled melanocytic tumor cells. A sentinel lymph node biopsy was negative, and no recurrence was noted 1 year later. We reviewed 173 previously published cases of PEM or so-called animal-type melanoma in the literature. Among the 173 cases and our case, extremities were the most common sites of occurrence (52/129, 40.3%), and most of the depth of invasions were Clark level IV and V [76/114 (66.7%) and 33/114 (28.9%), respectively]. Lymph nodes metastasis was noted in 39/89 (43.8%) of the cases being investigated. Only two cases died of the disease with visceral metastasis. Thus, a more advanced level of invasion and the presence of lymph node metastasis did not imply a definitely malignant clinical course, because spreading beyond lymph nodes was rare (5/174, 2.9%). However, long-term follow-up with more cases and further research are needed to fully delineate the true biological nature of this pigmented melanocytic tumor.
Introduction
Pigmented epithelioid melanocytoma (PEM) is an unusual variant of malignant melanoma with relatively indolent behavior. It was first described by Dick, 1 who noted its predilection for gray horses and named it as "equine-type melanoma" in 1832. In 1925, Darier 2 first described this kind of tumor in humans, and introduced the name "melanosarcoma." Since then, a small number of cases have been reported, and the name "animal-type melanoma" has been used. In 2004, Zembowicz 3 gave it the name "pigmented epithelioid melanocytoma" which was proposed to include animal-type melanoma and epithelioid blue nevus as malignant and benign ends of this histological spectrum. In 2006, Antony 4 named it as "pigment synthesizing melanoma." He thought that the name PEM implied a benign tumor according to the nomenclature system. However, PEM is still the most common name being used in current literature. PEM is extremely rare. It affects all age groups. The prognosis is relatively good compared to conventional malignant melanoma. However, there are only limited cases and results of long-term follow-up, and the role of sentinel lymph node biopsy (SLNB) in the disease is still controversial. We reviewed 173 cases in the literature, regarding the results of gender ratio, location, Clark's level of invasion, and outcomes such as lymph node metastasis, distant metastasis and follow-up.
Case presentation
A 12-year-old Taiwanese girl (Fitzpatrick type IV) presented with an asymptomatic brown-black nodule, measuring 0.4 Â 0.4 cm, on the third finger web of her right hand ( Figure 1A ). The nodule had been observed for 3e4 years, increasing in size in a few months. There was no past history or family history of malignant melanoma, blue nevus or Carney complex. No palpable lymph node or history of frequent sun exposure was noted. The lesion was excised and histology showed predominant formation of heavily pigmented epithelioid cells ( Figures 1B and 1C) and some spindled cells with large nuclei, prominent nucleoli ( Figure 1D ) and rare mitosis ( Figure 1D , arrow). Ulceration was also noted ( Figure 1B ). Neither However, due to the disfigured lesion, the patient wore a glove at all times, and a dividing line of fair-colored and tan-colored skin on the forearm was noted (arrow). junctional nests nor epidermal spread was found. However, focal vascular invasion was seen at the junction of deep dermis and subcutis ( Figure 1E , arrow). Tumor cells were positive for S-100 protein ( Figure 1F ), but negative for HMB-45 ( Figure 1G ) and Melan-A ( Figure 1H ). The Ki-67 proliferative index was low (approximately 6%, Figure 1I) . A pigmented epithelioid melanocytoma, so-called animal-type melanoma, was diagnosed. The depth of invasion was classified as Clark level V, with maximum thickness of 3.8 mm. Wide excision with sentinel lymph node sampling and full-thickness skin graft was performed at another hospital. No residual tumor was found, and the sentinel lymph node was negative. Positron emission tomography scan was also negative. The patient was followed for 1 year, and neither local recurrence nor metastasis occurred ( Figure 1J ).
Discussion
PEM is a distinctive clinicopathological variant of melanocytic tumor of unknown malignant potential. It is characterized by its unique feature of indolent behavior compared to conventional melanoma. While Zembowicz et al. 3 reported an equal sex predilection for younger individuals without ethnic predominance, Antony et al. 4 reported that middle-aged to old adults have a predilection for the disease. Extremities were the most common sites of occurrence, followed by trunk and head and neck. 3, 4 Histopathologically, these lesions often have a wedge-shaped configuration and are composed of heavily pigmented dermal melanocytic tumor cells with a mixture of epithelioid and spindled cells. Mitosis can be seen, but is rare. The histopathological differential diagnoses of PEM include cellular blue nevus, malignant blue nevus, Spitz nevus, deep penetrating nevus and epithelioid blue nevus. The most specific differentiating feature between PEM and cellular blue nevus is the presence of abundant epithelioid cells in PEM. 5 However, it is challenging to differentiate between PEM and malignant blue nevus, since they both have atypical epithelioid cells. The presence of significant nuclear pleomorphism, hyperchromatism, prominent eosinophilic nucleoli, brisk mitotic activity, atypical mitoses and tumor necrosis are important features for malignant blue nevus. Besides, malignant blue nevus is classically defined as malignant melanoma arising within a preexisting blue nevus or the site of prior biopsy/excision of a blue nevus. 5 Spitz nevus usually presents with maturation and prominent demarcation, which can be distinguished from PEM. 4 Deep penetrating nevus is a distinctive deeply pigmented lesion showing overlapping features with blue nevus and Spitz nevus. 6 Histologically, deep penetrating nevus shows a typical wedge-shaped, deeply pigmented dermal tumor with a junctional component. Tumor cells are arranged in nests or bundles and have a short spindle-shaped or, less commonly, round morphology. In addition, a thin rim of sustentacular cells is present around the edges of many nests. One characteristic feature of deep penetrating nevus, is the extension of melanocytes along the path of adnexal structures, blood vessels and nerve bundles, which is absent in PEM. Epithelioid blue nevus, which is associated with the Carney complex, but also occurs sporadically, is described as being histopathologically indistinguishable from PEM, and the relationship between these two entities is still not entirely clear. 3e5 Zembowicz et al. 3 proposed the term PEM to compose of animaltype melanoma and epithelioid blue nevus as malignant and benign ends of this histological spectrum. Murali et al. 7 suggested that a subset of epithelioid blue nevus remained and was distinct from PEM by less cell density and less pigmentation. Zembowicz et al. 3 mentioned that ulceration was the only feature more common in PEM than epithelioid blue nevus of Carney complex. In our case, the tumor was highly cellular, heavily pigmented and showed cellular atypia with ulceration, and, in our opinion, was best considered as PEM. Molecular testing of histologically ambiguous primary cutaneous melanocytic tumors by using techniques such as comparative genomic hybridization or fluorescence in situ hybridization (FISH) may assist in establishing a diagnosis of melanoma if multiple chromosomal aberrations are identified. 8 However, there was still a limited result in the field of PEM. There were only two cases of congenital PEM being studied by FISH, and one had focal FISH positivity. 9 This study revealed that there were still limits in the technique for the diagnosis of PEM. Thus, a definitive diagnosis for puzzling lesions such as PEM should not rely on molecular data alone. The associations between clinical, histopathological and FISH data are needed. 9 Another molecular study showed a loss of expression of protein kinase A regulatory subunit 1a (R1a coded by the PRKAR1A gene) in 28 of 34 (82%) PEMs and in 8 of 8 Carney complex-associated epithelioid blue nevus, whereas R1a was expressed in 291 of 292 various benign and malignant non-PEM melanocytic lesions and in 5 of 5 equine melanomas. 10 The results of these studies suggested that PEM and Carney complexassociated epithelioid blue nevus are closely related neoplasms. Although being a morphological mimic, PEM is a distinct melanocytic tumor that differs in molecular pathogenesis from cellular blue nevi, malignant blue nevi, Spitz nevi, deep penetrating nevi, melanomas of various types and equine melanomas. We reviewed 17 literature publications from the year 1999 to 2010 and identified 173 previously reported cases (Table 1) . Among the cases with detailed data (including our case), there were 72 (55.8%) females and 57 (44.2%) males. There were four cases of congenital PEM. The most common sites of occurrence were the extremities (52/129; 40.3%), followed by trunk (36/129; 27.9%) and head and neck (36/129; 27.9%). Most of the tumors at the time of diagnosis involved Clark's level IV (76/114; 66.7%) or Clark's level V (33/114; 28.9%). Among the 174 cases, 39 cases (22.4%) had lymph node metastasis; only 5 cases (2.9%) had spread beyond lymph nodes. The most common site of visceral metastasis was liver (4/5, 80%). Two cases (1.1%) died of the disease due to visceral metastasis during follow-up (Table 2) . Although presenting at deep levels, PEM has better prognosis than conventional melanoma.
The true nature of PEM remains controversial. Many consider it a tumor of uncertain malignant potential or possibly a low-grade malignancy. Although it has a tendency to have deep invasion and even spread to regional lymph nodes, distant metastasis is rare. Even if it recurs or metastasizes, it has a better prognosis compared to conventional malignant melanoma with the same depth of invasion.
3e5, 11 Ludgate et al. 11 and Zembowicz et al. 3 reported SLNB positive rates of 47% (8/17) and 46% (11/24), respectively. However, in contrast to these two studies, Orlandi et al. 12 and Scolyer et al. 13 reported no positive SLNB in 7 and 5 patients with PEM, respectively (Table 1) . Among the 174 cases we reviewed, the positive rate of lymph node metastasis either confirmed by SLNB or complete lymph node dissection (CLND) was 43.8% (39/89), accounting for 22.4% of the total number of cases. The variation in these results may be due to the small number of cases in previous reports, and the criteria for performing a SLNB/CLND not being clearly established. Thus, the positive rate in cases undergoing lymph nodes sampling or dissection may be over-estimated due to deeper tumor cell invasion or a more progressive clinical course. Regardless of the relatively high rate of lymph node metastasis, there were only 2.9% of cases whose disease had spread beyond the lymph nodes (Table 2) . Thus, whether SLNB or CLND is needed for all cases of PEM is still controversial. Some suggested that PEM may not need to be managed as aggressively as conventional melanoma, due to its indolent behavior, 14 while others recommended SLNB as a "diagnostic procedure" in an attempt to better recognize the biological potential of these tumors. 3 Ludgate et al. 11 recommended performing a SLNB in PEM that is greater than 1 mm in Breslow depth or 0.75e1 mm with other adverse features such as ulceration or a high mitotic rate. The longest follow-up to date was reported after a median follow-up period of 67 months (range from 39 to 216 months) of 26 patients by Mandal et al. 15 All of these patients were alive and free of disease during the follow-up period. These results
showed that the presence of lymph node metastases in PEM does not necessarily imply a malignant clinical course. Examination of sentinel lymph nodes by lymphoscintigraphy and assessment by clinical examination and ultrasound for early detection of metastasis, rather than invasive SLNB, have been suggested. 15 In summary, although there are still debates on the nomenclature of this entity, PEM is the most common name used currently; it can be categorized as a borderline melanocytic tumor or a lowgrade melanoma. PEM is characterized by a predominantly intradermal deeply pigmented melanocytic lesion, composed mainly of epithelioid and spindled cells. Some cytologic atypia can be found, but mitotic activity is low. PEM may involve regional lymph nodes, but it has a limited ability to spread beyond the lymph nodes. Although it showed indolent behavior and an overall good prognosis in the 174 cases we reviewed, its potential for aggressive behavior should not be ignored. Whether SLNB should be performed as a staging procedure in every case of PEM remains controversial. Longer periods of follow-up with more cases and further molecular studies for PEM are needed to fully delineate the true biological nature of this disease. 
